{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T15:46:50Z","timestamp":1769096810167,"version":"3.49.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicon"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.toxicon.2012.10.020","type":"journal-article","created":{"date-parts":[[2012,11,23]],"date-time":"2012-11-23T05:46:49Z","timestamp":1353649609000},"page":"141-152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":82,"special_numbering":"C","title":["Evidence-based review and assessment of botulinum neurotoxin for the treatment of secretory disorders"],"prefix":"10.1016","volume":"67","author":[{"given":"Markus","family":"Naumann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk","family":"Dressler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Hallett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Jankovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giampietro","family":"Schiavo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen R.","family":"Segal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Truong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxicon.2012.10.020_bib1","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/00006534-200207000-00039","article-title":"Hyperhidrosis: a review of current management","volume":"110","author":"Atkins","year":"2002","journal-title":"Plast. Reconstr. Surg."},{"key":"10.1016\/j.toxicon.2012.10.020_bib2","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/00042728-200503000-00002","article-title":"Double-blind, randomized, placebo-controlled pilot study of the safety and efficacy of Myobloc (botulinum toxin type B) for the treatment of palmar hyperhidrosis","volume":"31","author":"Baumann","year":"2005","journal-title":"Dermatol. Surg."},{"key":"10.1016\/j.toxicon.2012.10.020_bib3","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1365-4632.2004.02531.x","article-title":"Pilot study of the safety and efficacy of Myobloc (botulinum toxin type B) for treatment of axillary hyperhidrosis","volume":"44","author":"Baumann","year":"2005","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.toxicon.2012.10.020_bib4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.anai.2009.11.020","article-title":"Evaluating approved medications to treat allergic rhinitis in the United States: an evidence-based review of efficacy for nasal symptoms by class","volume":"104","author":"Benninger","year":"2010","journal-title":"Ann. Allergy Asthma. Immunol."},{"key":"10.1016\/j.toxicon.2012.10.020_bib5","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1345\/aph.1H381","article-title":"Botulinum toxin A in the treatment of sialorrhea","volume":"41","author":"Benson","year":"2007","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.toxicon.2012.10.020_bib6","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00702-007-0812-7","article-title":"Evidence for effectiveness of botulinum toxin for hyperhidrosis","volume":"115","author":"Bhidayasiri","year":"2008","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.toxicon.2012.10.020_bib7","doi-asserted-by":"crossref","first-page":"96","DOI":"10.2174\/187152809788462653","article-title":"Update on the medical treatment of allergic rhinitis","volume":"8","author":"Cingi","year":"2009","journal-title":"Inflamm. Allergy Drug Targets"},{"key":"10.1016\/j.toxicon.2012.10.020_bib8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.fsc.2006.10.002","article-title":"Diagnosis, impact, and management of focal hyperhidrosis: treatment review including botulinum toxin therapy","volume":"15","author":"Cohen","year":"2007","journal-title":"Facial Plast. Surg. Clin. North. Am."},{"key":"10.1016\/j.toxicon.2012.10.020_bib9","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00702-010-0372-0","article-title":"Comparing Botox and Xeomin for axillar hyperhidrosis","volume":"117","author":"Dressler","year":"2010","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.toxicon.2012.10.020_bib10","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/hed.10262","article-title":"Treatment of gustatory sweating (Frey's syndrome) with botulinum toxin A","volume":"25","author":"Eckardt","year":"2003","journal-title":"Head Neck"},{"key":"10.1016\/j.toxicon.2012.10.020_bib11","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1053\/joms.2000.16625","article-title":"The effect of local injection of botulinum toxin A on the parotid gland of the rat: an immunohistochemical and morphometric study","volume":"58","author":"Ellies","year":"2000","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.toxicon.2012.10.020_bib12","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/mds.23473","article-title":"Botulinum toxin A versus B in sialorrhea: a prospective, randomized, double-blind, crossover pilot study in patients with amyotrophic lateral sclerosis or Parkinson's disease","volume":"26","author":"Guidubaldi","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.toxicon.2012.10.020_bib13","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1056\/NEJM200102153440704","article-title":"Botulinum toxin A for axillary hyperhidrosis (excessive sweating)","volume":"344","author":"Heckmann","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.toxicon.2012.10.020_bib14","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/mus.21213","article-title":"Randomized double-blind study of botulinum toxin type B for sialorrhea in ALS patients","volume":"39","author":"Jackson","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.toxicon.2012.10.020_bib15","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1542\/peds.2003-1104-L","article-title":"Effect of botulinum toxin in the treatment of drooling: a controlled clinical trial","volume":"114","author":"Jongerius","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.toxicon.2012.10.020_bib16","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/mds.20793","article-title":"Botulinum toxin type A for drooling in Parkinson's disease: a double-blind, randomized, placebo-controlled study","volume":"21","author":"Lagalla","year":"2006","journal-title":"Mov. Disord."},{"key":"10.1016\/j.toxicon.2012.10.020_bib17","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1212\/WNL.61.9.1279","article-title":"A randomized trial of botulinum toxin A for treatment of drooling","volume":"61","author":"Lipp","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.toxicon.2012.10.020_bib18","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.jaad.2007.01.009","article-title":"Botulinum toxin type A in the treatment of primary axillary hyperhidrosis: a 52-week multicenter double-blind, randomized, placebo-controlled study of efficacy and safety","volume":"56","author":"Lowe","year":"2007","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.toxicon.2012.10.020_bib19","first-page":"822","article-title":"Efficacy and safety of botulinum toxin type a in the treatment of palmar hyperhidrosis: a double-blind, randomized, placebo-controlled study","volume":"28","author":"Lowe","year":"2002","journal-title":"Dermatol. Surg."},{"key":"10.1016\/j.toxicon.2012.10.020_bib20","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/mds.10420","article-title":"Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism","volume":"18","author":"Mancini","year":"2003","journal-title":"Mov. Disord."},{"key":"10.1016\/j.toxicon.2012.10.020_bib21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2500\/aap.2007.28.2934","article-title":"The burden of allergic rhinitis","volume":"28","author":"Nathan","year":"2007","journal-title":"Allergy Asthma Proc."},{"key":"10.1016\/j.toxicon.2012.10.020_bib22","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1136\/bmj.323.7313.596","article-title":"Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial","volume":"323","author":"Naumann","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.toxicon.2012.10.020_bib23","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1212\/01.wnl.0000311390.87642.d8","article-title":"Assessment: botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology","volume":"70","author":"Naumann","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.toxicon.2012.10.020_bib24","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/ana.410420619","article-title":"Treatment of gustatory sweating with botulinum toxin","volume":"42","author":"Naumann","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.toxicon.2012.10.020_bib25","first-page":"480","article-title":"Long-term quantitative benefits of botulinum toxin type A in the treatment of axillary hyperhidrosis","volume":"28","author":"Odderson","year":"2002","journal-title":"Dermatol. Surg."},{"key":"10.1016\/j.toxicon.2012.10.020_bib26","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1212\/01.WNL.0000101713.81253.4C","article-title":"A double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson's disease","volume":"62","author":"Ondo","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.toxicon.2012.10.020_bib27","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1212\/WNL.57.11.2095","article-title":"Botulinum toxin type A in primary palmar hyperhidrosis: randomized, single-blind, two-dose study","volume":"57","author":"Saadia","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.toxicon.2012.10.020_bib28","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.1365-2133.1997.tb02139.x","article-title":"Double-blind trial of botulinum A toxin for the treatment of focal hyperhidrosis of the palms","volume":"136","author":"Schnider","year":"1997","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.toxicon.2012.10.020_bib29","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1398-9995.2008.01909.x","article-title":"Pharmacotherapy of allergic rhinitis: a pharmaco-economic approach","volume":"64","author":"Simoens","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.toxicon.2012.10.020_bib30","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/j.1365-2133.2003.05620.x","article-title":"A double-blind, randomized, comparative study of Dysport vs. Botox\u00a0in primary palmar hyperhidrosis","volume":"149","author":"Simonetta Moreau","year":"2003","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.toxicon.2012.10.020_bib31","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1111\/j.1524-4725.2006.32331.x","article-title":"A double-blind, randomized, comparative study of two type A\u00a0botulinum toxins in the treatment of primary axillary hyperhidrosis","volume":"33","author":"Talarico-Filho","year":"2007","journal-title":"Dermatol. Surg."},{"key":"10.1016\/j.toxicon.2012.10.020_bib32","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00702-007-0861-y","article-title":"Evidence for the effectiveness of\u00a0botulinum toxin for sialorrhoea","volume":"115","author":"Truong","year":"2008","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.toxicon.2012.10.020_bib33","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1080\/00016489.2003.11720744","article-title":"Effect of botulinum toxin type A on nasal symptoms in patients with allergic rhinitis: a double-blind, placebo-controlled clinical trial","volume":"123","author":"Unal","year":"2003","journal-title":"Acta Otolaryngol."},{"key":"10.1016\/j.toxicon.2012.10.020_bib34","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/j.1365-2133.2007.07760.x","article-title":"Treatment of axillary hyperhidrosis with botulinum toxin type A reconstituted in lidocaine or in normal saline: a randomized, side-by-side, double-blind study","volume":"156","author":"Vadoud-Seyedi","year":"2007","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.toxicon.2012.10.020_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pop.2007.09.001","article-title":"Allergic rhinitis","volume":"35","author":"Weber","year":"2008","journal-title":"Prim. Care"},{"key":"10.1016\/j.toxicon.2012.10.020_bib36","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1055\/s-0028-1112115","article-title":"Successful treatment of drooling in children with neurological disorders with botulinum toxin A or B","volume":"39","author":"Wilken","year":"2008","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.toxicon.2012.10.020_bib37","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.otohns.2008.06.031","article-title":"A comparison of the effects of botulinum toxin A and steroid injection on nasal allergy","volume":"139","author":"Yang","year":"2008","journal-title":"Otolaryngol. Head Neck Surg."}],"container-title":["Toxicon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010112007878?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010112007878?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,21]],"date-time":"2018-10-21T06:21:58Z","timestamp":1540102918000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041010112007878"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":37,"alternative-id":["S0041010112007878"],"URL":"https:\/\/doi.org\/10.1016\/j.toxicon.2012.10.020","relation":{},"ISSN":["0041-0101"],"issn-type":[{"value":"0041-0101","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evidence-based review and assessment of botulinum neurotoxin for the treatment of secretory disorders","name":"articletitle","label":"Article Title"},{"value":"Toxicon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxicon.2012.10.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}